Nuvalent Highlights Presentation of Clinical Data at ESMO 2024 for Parallel Lead Programs for ROS1 and ALK-positive NSCLC and Accelerated Development Timelines Read more
Argentina’s parallel peso strengthens on new economic measures, stock index plummets By Reuters Read more